Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - sildenafil citrate 70.24mg equivalent to sildenafil 50 mg - film coated tablet - 50 mg - active: sildenafil citrate 70.24mg equivalent to sildenafil 50 mg excipient: calcium hydrogen phosphate croscarmellose sodium hypromellose e-5 magnesium stearate microcrystalline cellulose opadry blue 31k80865 - treatment of erectile dysfunction in adult males

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

bayer new zealand limited - fluconazole 150mg - capsule - 150 mg - active: fluconazole 150mg excipient: colloidal silicon dioxide gelatin lactose monohydrate magnesium stearate maize starch opacode black s-1-17823 sodium laurilsulfate titanium dioxide water - canesoral fluconazole capsule, given orally, is indicated for vaginal candidiasis.

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

bayer new zealand limited - fluconazole 150mg; clotrimazole 10 mg/g - combination - 150mg & 10mg/g - active: fluconazole 150mg excipient: colloidal silicon dioxide gelatin lactose monohydrate magnesium stearate maize starch opacode black s-1-17823 sodium laurilsulfate titanium dioxide water active: clotrimazole 10 mg/g excipient: benzyl alcohol cetostearyl alcohol cetyl palmitate octyldodecanol polysorbate 60 purified water sorbitan stearate - vaginal candidiasis. cream can be used for relief of external itching/irritation and the management of candida vulvovaginitis or infection of the peri-anal area.

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - palbociclib 100mg - capsule - 100 mg - active: palbociclib 100mg excipient: colloidal silicon dioxide gelatin   iron oxide red   iron oxide yellow   lactose monohydrate magnesium stearate microcrystalline cellulose opacode white s-1-7085 sodium starch glycolate titanium dioxide   - ibrance is indicated for the treatment of hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her2)-negative locally advanced or metastatic breast cancer: - in combination with an aromatase inhibitor; - in combination with fulvestrant in women who have received prior endocrine therapy. in pre- or peri-menopausal women, the endocrine therapy should be combined with a luteinizing hormone-releasing hormone (lhrh) agonist.

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - palbociclib 125mg - capsule - 125 mg - active: palbociclib 125mg excipient: colloidal silicon dioxide gelatin   iron oxide red   iron oxide yellow   lactose monohydrate magnesium stearate microcrystalline cellulose opacode white s-1-7085 sodium starch glycolate titanium dioxide   - ibrance is indicated for the treatment of hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her2)-negative locally advanced or metastatic breast cancer: - in combination with an aromatase inhibitor; - in combination with fulvestrant in women who have received prior endocrine therapy. in pre- or peri-menopausal women, the endocrine therapy should be combined with a luteinizing hormone-releasing hormone (lhrh) agonist.

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - palbociclib 75mg - capsule - 75 mg - active: palbociclib 75mg excipient: colloidal silicon dioxide gelatin   iron oxide red   iron oxide yellow   lactose monohydrate magnesium stearate microcrystalline cellulose opacode white s-1-7085 sodium starch glycolate titanium dioxide   - ibrance is indicated for the treatment of hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her2)-negative locally advanced or metastatic breast cancer: - in combination with an aromatase inhibitor; - in combination with fulvestrant in women who have received prior endocrine therapy. in pre- or peri-menopausal women, the endocrine therapy should be combined with a luteinizing hormone-releasing hormone (lhrh) agonist.

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - atovaquone 250mg; proguanil hydrochloride 100mg - film coated tablet - active: atovaquone 250mg proguanil hydrochloride 100mg excipient: colloidal silicon dioxide hyprolose magnesium stearate microcrystalline cellulose opadry brown 03c86943 poloxamer sodium starch glycolate tolpovidone i 131 - promozio (250mg atovaquone/100mg proguanil hydrochloride) is indicated for: · prophylaxis of plasmodium falciparum malaria in adults · treatment of plasmodium falciparum malaria in adults.

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - crizotinib 200mg;  ;   - capsule - 200 mg - active: crizotinib 200mg     excipient: calcium hydrogen phosphate colloidal silicon dioxide gelatin iron oxide red magnesium stearate microcrystalline cellulose sodium starch glycolate tekprint black sw-9008 titanium dioxide - xalkori is indicated for the treatment of patients with anaplastic lymphoma kinase (alk)-positive advanced non-small cell lung cancer (nsclc). xalkori is indicated for the treatment of patients with ros1-positive advanced non-small cell lung cancer (nsclc).

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - crizotinib 250mg;  ;   - capsule - 250 mg - active: crizotinib 250mg     excipient: calcium hydrogen phosphate colloidal silicon dioxide gelatin iron oxide red magnesium stearate microcrystalline cellulose sodium starch glycolate tekprint black sw-9008 titanium dioxide - xalkori is indicated for the treatment of patients with anaplastic lymphoma kinase (alk)-positive advanced non-small cell lung cancer (nsclc). xalkori is indicated for the treatment of patients with ros1-positive advanced non-small cell lung cancer (nsclc).

Nowa Zelandia - angielski - Ministry for Primary Industries

upl new zealand limited - triclopyr - triclopyr 120 g/litre - herbicide